SINOVAC BIOTECH LTD Statutory Accounting Practices, Statutory Capital and Surplus, Balance
SINOVAC BIOTECH LTD (SVA) had Statutory Accounting Practices, Statutory Capital and Surplus, Balance of $1.59 billion as of 2025-12-31, per its 20-F filed 2026-06-05.
Financial Statements › Notes › Financial Services
us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance · last filed 2026-06-05
- 2025-12-31: Statutory Accounting Practices, Statutory Capital and Surplus, Balance $1.59B.
- 2024-12-31: Statutory Accounting Practices, Statutory Capital and Surplus, Balance $1.58B.
- 2023-12-31: Statutory Accounting Practices, Statutory Capital and Surplus, Balance $1.54B.
- 2022-12-31: Statutory Accounting Practices, Statutory Capital and Surplus, Balance $1.54B.
| Period end | Statutory Accounting Practices, Statutory Capital and Surplus, Balance |
|---|---|
| 2025-12-31 | $1.59B 20-F · filed 2026-06-05 |
| 2024-12-31 | $1.58B 20-F · filed 2026-06-05 |
| 2023-12-31 | $1.54B 20-F · filed 2026-04-30 |
| 2022-12-31 | $1.54B 20-F · filed 2026-04-30 |
| 2021-12-31 | $1.51B 20-F · filed 2026-04-30 |
| 2020-12-31 | $50.38M 20-F · filed 2022-04-29 |
| 2019-12-31 | $33.53M 20-F · filed 2021-04-22 |
| 2018-12-31 | $26.64M 20-F · filed 2020-04-30 |